July 29, 1999
Juan Carlos Scornik, M.D.
Professor and Chief, Immunology and Transplantation
University of Florida College of Medicine
Department of Pathology
Gainesville, FL 32610-0275
Telephone: (904) 392-2606 Fax: (904)392-4693
Born November 20, 1942 in La Plata, Argentina
Children: Hugo (born 3/25/69)
Esteban (born 9/12/71)
1966 M.D. 1966, University of La Plata Medical School, Argentina.
1967-1971 Intern and resident in Hematology, San Martin Hospital, La Plata, Argentina.
1970-1972 Research Fellow, Institute of Hematologic Investigations, Buenos Aires,
1972-1973 Research Associate, Department of Pathology, University of Chicago.
1974-1975 Fellow, Department of Clinical Chemistry and Laboratory Medicine 1974-1975,
M.D. Anderson Hospital, Houston, Texas.
1975 Special Mention for Research for Fellows, M.D. Anderson Hospital,
ACADEMIC APPOINTMENTS (University of Florida College of Medicine)
1976-1981 Assistant Professor of Pathology
1981-1987 Associate Professor
1988-1992 Director, Pathology Residency Program
1989-1992 Promotion and Tenure Committee, University of Florida College of Medicine.
1990-1993 Medical Student Selection Committee, University of Florida College of
1991-1994 University of Florida Faculty Senate.
1982 NIH Ad-hoc reviewer, site visit Center for Blood Research,
1986 NIH reviewer, Transfusion Medicine Award.
1987 NIH reviewer, Transfusion Medicine Award
1987 American Red Cross, Research Grants reviewer
1977-DATE Laboratory Inspector, College of American Pathologists (CAP)
1990-1993 Chairman, Clinical Affairs Committee, ASHI (American Society
of Histocompatibility and Immunogenetics)
1991-DATE ASHI-CAP Histocompatibility Proficiency Testing Committee.
1991-DATE: Committee member
1992-DATE: Flow cytometry subcommittee chair
1996-DATE: Committee vice-chair for the CAP
1992-1994 Council Member, ASHI
1993-DATE Editorial Board, journal Transplantation
1997 Abstract reviewer, ASHI Annual meeting
1976-1980 Director, Clinical Laboratories, Veterans Administration Medical Center,
1980-DATE Chief, Immunology and Transplantation, Department of Pathology, University of
1980-1983 Director, Blood Bank, Shands Hospital, University of Florida.
1980-1983 Chairman, Transfusion Committee, Shands Hospital, University of Florida
1980-DATE Member, Transplantation Committee, Shands Hospital, University of Florida.
1982-1994 Director, Outpatient Laboratory, Shands Hospital, University of Florida.
1985-1988 Clinical Laboratory Consultant, State of Florida Reception and Medical Center,
Lake Butler, FL.
1987-1990 Clinical Laboratory Consultant, State of Florida Sunland Center, Gainesville, FL.
1988-DATE Clinical Immunology Laboratory Consultant, VA Medical Center, Gainesville,
1997 Consultant, Tissue Bank (Biodynamics International).
American Association of Immunologists
American Society of Histocompatibility and Immunogenetics
American Society of Transplant Physicians
The Transplantation Society
Fellow, College of American Pathologists
Florida Association of Pathologists
State of Florida
District of Columbia
1976 Clinical Pathology, American Board of Pathology
STUDENTS (Chair, Advisory Committee)
1981 Phillip Ruiz: M.D., Ph.D.
Current Position: Associate Professor and Chief, Immunopathology,
University of Miami School of Medicine.
1985 Daniel J. Cook: Ph.D.
Current Position: Director, Histocompatibility Laboratory, Cleveland
1982 Joan Appleyard: M.S.
1984 Rebeca Rivera: M.S.
1989 Eric T. Everett: M.S.
1994-1995 Fritz E Lower, MD.
Current Position: Assistant Professor and Associate Director,
Histocompatibility Laboratory, University of Kentucky Medical Center.
1977-1980 Principal investigator. In vivo role of antibody-dependent cell-mediated
cytotoxicity. Veterans Administration Research Service, $40,000/year.
1979-1983 Principal investigator. Anti-lymphocyte serum in renal transplantation. State of
1981-1984 Principal investigator. Establishment of an HLA typed donor file. American
Cancer Society, $25,000/year.
1983-1987 Principal investigator. Effect of blood transfusions after transplantation surgery.
National Institutes of Health (RO1), $50,000/year.
1985-1988 Principal investigator. Immunogenicity of HLA matched blood transfusions.
National Institutes of Health (RO1), $80,000/year.
1987-1991 Principal investigator. Effect of blood transfusions after transplantation surgery
(Renewal). National Institutes of Health (RO1), $80,000/year.
1989-1996 Co-investigator. Trial to reduce alloimmunization to platelets (TRAP). National
Institutes of Health (Multicenter clinical trial). K.J. Kao, principal investigator.
1991-1995 Principal investigator. Immunosuppression for HLA sensitization. Sandoz
Pharmaceuticals, $205,000 total award.
1. Scornik, J.C.: Complement-dependent IgG Receptor Function in Lymphoid Cells.
Selected for reproduction in James T. Barrett's Textbook of Immunology, 3rd Edition.
St. Louis, Mosby, 1978, pp. 463.
2. Scornik, J.C.: In Vivo and In Vitro ADCC by Peritoneal Cells from Mice.
IN:"Macrophage-mediated Antibody-dependent Cellulary Cytotoxicity", Hillel S. Koren,
Editor. Marcell Dekker, Inc., publisher. Immunology Series 21, 1983, pp. 263.
3. Scornik, J.C.: Flow cytometry crossmatch. IN: "ASHI Manual". American Society of
Histocompatibility and Immunogenetics, 1989.
4. Scornik, J.C.: Role of flow cytometry in clinical transplantation. IN: "Clinical Flow
Cytometry". Bauer, Duque and Shankey, editors. Williams and Wilkins, Baltimore,
5. Scornik, J.C. Mechanisms of alloimmunization to HLA Class I antigens. In "Clinical
decisions in platelet therapy". S.R. Kurtz and D.B. Brubaker, editors. American
Association of Blood Banks, Bethesda, MD, 55:1992.
6. Pfaff, W.W., Patton, P.R., Howard, R.J., Brunson, M.E., Ramos, E.L., Fennell, R.S.,
Peterson, J.C., Scornik, J.C. Immunosuppression without prophilactic antilymphocyte
preparations. In: "Clinical Transplants 1992". P.I. Terasaki, editor. UCLA Tissue Typing
Laboratory, Los Angeles, CA, 1993. pp. 237.
7. Scornik JC, Cecka JM. Immune responsiveness and renal transplantation. In , Clinical
Transplants 1996". JM Cecka, PI Terasaki, editors. UCLA Tissue Typing Laboratory,
Los Angeles, California, 1997. Pp 373.
1. Scornik, J.C., Giraudo Conesa, L.C. and Bachmann, A.E.: Increased RNA synthesis in
unstimulated human leukocyte cultures. Exptl. Cell Res 1971, 69:444.
2. Scornik, J.C. and Macario, A.J.L.: Tritiated uridine uptake by histiomonocyte cells in
murine lymphoid tissues. Acta Physiol. Lat. Amer 1971, 21:91.
3. Scornik, J.C., Conesa, L.C.G., Saal, F. and Brown, M.: RNA synthesis by human and
murine mononuclear phagocytic cells. Medicine 1971, 31:425.
4. Scornik, J.C., Cosenza, H., Lee, W., Kohler, H. and Rowley, D.A.:
Antibody-dependent Cell-mediated cytotoxicity. 1. Differentiation from antibody
independent cell-mediated cytotoxicity by normal IgG. J. Immunol, 1974, 113:1510.
5. Scornik, J.C.: Antibody-dependent cell-mediated cytotoxicity. II. Early interactions
between effector and target cells. J. Immunol 1974, 113: 1519.
6. Scornik, J.C. and Cosenza, H.: Antibody-dependent cell-mediated cytotoxicity. III.
Two functionally different effector cells. J. Immunol 1974, 113: 1527.
7. Scornik, J.C., Salinas, M.C. and Drewinko, B.: IgG-dependent clearance of red blood
cells in IgG myeloma patients. J. Immunol 1975, 115:901.
8. Scornik, J.C. and Drewinko, B.: Receptors for IgG and complement in human spleen
lymphoid cells. Preferential binding of particulate immune complexes through
complement receptors. J. Immunol 1975, 115:1223.
9. Scornik, J.C.: Complement-dependent IgG receptor function in lymphoid cells.
Science 1976, 192:563.
10. Scornik, J.C. and Klein, P.A.: Antibody-dependent lysis of tumor cells in vivo. I. Early
lysis of tumor cells. J. Natl. Cancer Inst 1978, 61:1143.
11. Scornik, J.C. and Klein, P.A.: Antibody-dependent lysis of tumor cells in vivo. II.
Elimination of 51Cr as a measurement of cytolysis. J. Natl. Cancer Inst 1978, 61:1149.
12. Scornik, J.C. and Klein, P.A.: Antibody-dependent cell-mediated damage of target
cells. Transplantation 1978, 26:356.
13. Scornik, J.C., Ruiz, P. and Hoffman, E.M.: Suppression of cell-mediated tumor cell
lysis and complement-induced cytotoxicity by trypan blue. J. Immunol 1979, 123:1278.
14. Ruiz, P. and Scornik, J.C.: Role of monocytes, alloantigens and individual reactivity in
the response of human lymphocytes to mitogenic factor. J. Immunol 1982, 128:1289.
15. Howard, R.J., Pfaff, W.W., Fennell, R.S., Mahoney, J.J., Scornik, J.C. Finlayson, B.
and Walker, R.D.: 500 renal transplants at the University of Florida; 1966-1982. J.
Florida Med. Assoc. October, 1982.
16. Scornik, J.C., Ireland, J., Howard, R.J., Pfaff, W.W. and Fennell, R.S.: Sensitization by
blood transfusions in previously transplanted patients. Transplantation 1983, 35:505.
17. Appleyard, J., Scornik, J.C., Braylan, R.C. and Benson, N.A.: Distinctive expression of
the T4 antigen in normal and stimulated lymphocytes. Cellular Immunology 1983,
18. Shaut, D.M., Ireland, J., Scornik, J.C. and Peck, A.B.: Lack of shared
lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed
lymphocyte typing cells. Human Immunology 1983, 7:105.
19. Spitalnik, S., Pfaff, W.W., Cowles, J., Ireland, J., Scornik, J.C. and Blumberg, N.:
Humoral immunity to Lewis blood group antigens correlates with renal transplant
rejection. Transplantation 1984, 37:265.
20. Scornik, J.C., Ireland, J.E., Howard, R.J. and Pfaff, W.W.: Assessment of the risk for
broad sensitization by blood transfusions. Transplantation 1984, 37:249.
21. Howard, R.J., Scornik, J.C., Fennell, R.S. and Pfaff, W.W.: Results of kidney
retransplantation. Archives of Surgery 119, 1984, pp. 796.
22. Scornik, J.C., Ireland, J.E., Howard, R.J., Fennell, R.S. and Pfaff, W.W.: Role of
regular and leukocyte-free blood transfusions in the generation of broad sensitization.
Transplantation 1984, 38:594.
23. Pfaff, W.W., Fennell, R.S., Howard, R.J., Ireland, J.E. and Scornik, J.C.: Planned
random blood transfusion in preparation for transplantation: Sensitization and graft
survival. Transplantation 1984, 38:701.
24. Cook, D.J. and Scornik, J.C.: Purified HLA antigens to probe human alloantibody
specificity. Human Immunology 1985, 14:234.
25. Rivera, R. and Scornik, J.C.: HLA antigens on red cells. Implications for blood
transfusions and renal transplantation. Transfusion 1986, 29:375.
26. Cook, D.J. and Scornik, J.C.: Serum antibody reactivity of broadly sensitized patients
with HLA-matched peripheral blood T lymphocyte. Transplantation 1986, 41:447.
27. Kao, K.J., Cook, D.J. and Scornik, J.C.: Quantitative analysis of platelet surface HLA
by W6/32 anti-HLA monoclonal antibody. Blood 1986, 68:627.
28. Scornik, J.C. and LeFor, W.M.: Antibodies to crossreactive HLA antigens. Evaluation
by cytotoxicity, flow cytometry and inhibition of monoclonal antibody binding.
Transplantation 1987, 43:235.
29. Sanfilippo, F., Goeken, N., Niblack, G., Scornik, J.C. and Vaughn, W.K.: The effect of
first cadaver renal transplant HLA-A,B match on sensitization levels and re-transplant
rates following graft failure. Transplantation 1987, 43:240.
30. Scornik, J.C., Ireland, J.E., Salomon, D.R., Howard, R.J., Fennell, R.S. and Pfaff,
W.W.: Pretransplant blood transfusions in patients with previous pregnancies.
Transplantation 1987, 43: 449.
31. Everett, E.T., Kao, K.J. and Scornik, J.C.: Class I HLA molecules on human
erythrocytes. Quantitation and transfusion effects. Transplantation 1987. 44:123.
32. Scornik, J.C.: HLA-A2 epitopes recognized by alloantibodies from broadly sensitized
patients. Human Immunol 1987, 18:277.
33. Scornik, J.C., Salomon, D.R., Howard, R.J. and Pfaff, W.W.: Evaluation of antibody
synthesis in broadly sensitized patients. Transplantation 1988, 45:95.
34. Kao, K.J., Scornik, J.C., Riley, W.J., McQueen, C.F.: Association between HLA
phenotype and HLA concentration in plasma or platelets. Human Immunology 1988,
35. Wynn JJ, Pfaff WW, Patton PR, Peterson JC, Salomon DR, Fennell RS, Scornik JC,
Howard RJ. Late results of renal transplantation. Transplantation 1988, 45:329.
36. Pfaff W.W., Howard, R.J., Scornik, J.C., et al.: Incidental and purposeful random
donor blood transfusion. Transplantation 1989, 47:130.
37. Scornik, J.C., Salomon D.R, Lim, P.B, Howard, R.J. and Pfaff, W.W.: Posttransplant
antidonor antibodies and graft rejection. Transplantation 1989, 47:287.
38. Scornik, J.C., Salomon, D.R., Howard, R.J. and Pfaff, W.W.: Prevention of
transfusion-induced broad sensitization in renal transplant candidates. Transplantation
39. Kao, K.J. and Scornik, J.C.: Accurate quantitation of low number of leukocytes in
leukocyte-depleted blood components. Transfusion 1989, 29:774.
40. Kao, K.J., Scornik, J.C., McQueen, C. Evaluation of individual specificities of Class I
HLA on platelets by a newly developed monoclonal antibody. Human Immunol 1990,
41. Everett, E.T., Scornik, J.C., Davis, G., Kao, K.J. Induction of erythrocyte HLA
expression during interferon treatment and HIV infection. Human Immunology 1990,
42. Howard, R.J., Pfaff, W.W., Scornik, J.C., et al. Kidney transplantation in older patients.
Clinical Transplantation 1990, 4:181.
43. Akkoc, N. and Scornik, J.C. Intramolecular specificity of anti-HLA alloantibodies.
Human Immunology 1991, 30:91.
44. Scornik, J.C., Salomon, D.R., Fennell, R.S., Howard, R.J. and Pfaff, W.W. Evaluation
of immunosuppression as a treatment for pre-sensitization in renal transplant candidates.
Clinical Transplantation 1991, 5:121.
45. Akkoc, N. and Scornik, J.C. HLA epitope matching: Contribution of matched residues
to epitopes recognized by alloantibodies. Transplantation 1991, 52:903.
46. Scornik, J.C., LeFor, W.M., Cicciarelli, J.C., et. al. Hyperacute and acute kidney graft
rejection due to antibodies against B cells. Transplantation 1992, 54:61.
47. Kao, K.J., Scornik, J.C., Small, J.S. Enzyme-linked immunoassay for anti HLA
antibodies: An alternative to panel studies by lymphocytotoxicity. Transplantation 1993,
48. Scornik, J.C., Brunson M.E., Howard R.J., Pfaff, W.W. Alloimmunization, memory and
the interpretation of crossmatch results for renal transplantation. Transplantation 1992,
49. Scornik, J.C. Marrow transplants from unrelated donors (letter). N Engl J Med 1993,
50. Brunson, M.E., Lau, J Y-N, Davis G.L., Scornik, J.C., Howard, R.J., Pfaff, W.W. Non-
A, Non-B hepatitis and elevated serum aminotransferases in renal transplant patients:
Correlation with hepatitis C infection. Transplantation 1993. 56:1364.
51. Lau, J.Y-N., Davis, G.L., Brunson, M.E., Qian, K-P., Lin, H-J., Quan, S., DiNello, R.,
Polito, A.J., Scornik, J.C. Hepatitis C virus infection in renal transplant recipients.
Hepatology 1993, 18:1027.
52. Scornik JC, Brunson ME, Schaub B, Howard RJ, Pfaff WW. The crossmatch in renal
transplantation: Evaluation of flow cytometry as a replacement for standard cytotxicity.
Transplantation 1994, 57:621.
53. She JX, L. P. Zhang, Scornik JC, Wakeland E. Nucleotide sequence of a novel HLA-
DRB1 allele, DRB1*0810. Immunogenetics 1994, 39:78.
54. Scornik JC. The Immunology of Transplantation (Review article). J Florida Med Assn
55. Scornik JC, Pfaff WW, Howard RJ, Fennell RS, Ramos E, Peterson JC, Neiberger R.
Increased antibody responsiveness to blood transfusions in pediatric patients.
Transplantation 1994, 58:1361.
56. Howard RJ, Pfaff WW, Brunson ME, Scornik JC, Ramos EL, Peterson JC, Fennell RS,
Croker BP. Increased incidence of rejection in patients with delayed graft function. Clin
Transplantation 1994, 8:527.
57. Scornik, JC. Detection of alloantibodies by flow cytometry. Relevance to clinical
transplantation. Cytometry 1995, 22:259.
58. Howard RJ, Reed AI, Rosen CB, Scornik JC, Corpier CL, Fennell RS, Peterson JC,
Patton PR, Pfaff WW. Thirty years of transplantation: 2000 kidney transplants at the
University of Florida. J Florida MA 1997, 84:327.
59. Zaer F, Metz S, Scornik JC. Antibody screening by ELISA using pooled soluble HLA
in renal transplant candidates. Transplantation, 1997, 63:48
60. Fujita S, Rosen C, Reed A, Langham MR, Howard RJ, Lauwers GY, Scornik JC. The
significance of preformed anti-donor antibodies in liver transplantation. Transplantation,
61. Scornik JC, Bray RA, Pollack MS, Cook DJ, Marrari M, Duquesnoy R, Langley JW.
Multicenter evaluation of the flow cytometry T cell crossmatch. Results from the ASHI-
CAP proficiency testing program. Transplantation, 1997, 63:1440.
62. Ahmed S, Ayoub EM, Scornik JC, Wang CY, She JX. Poststreptococcal reactive
arthritis: Clinical characteristics and association with HLA-DR alleles. Arthritis and
Rheumatism, 1998, 41:1096.
63. Gian VG, Moreb JS, Mageed AA, Weeks FM, Scornik JC, Wingard JR. Successful
salvage using mismatched umbilical cord blood transplant in an adult with recurrent
acute myelogenous leukemia failing autologous peripheral blood progenitor cell
transplant. Bone Marrow Transpl 1998, 21:1197
64. Scornik JC, Zander DS, Baz MA, Donnelly WH, Staples ED. Susceptibility of lung
transplants to preforemed donor-specific HLA antibodies as detected by flow cytometry.
Transplantation 1999, 68:1542.
65. Scornik JC, Lauwers GY, Reed AI, Howard RJ, Dickson RC, Rosen CB. Infusion of
donor spleen cells and rejection in liver transplant recipients. Clinical Transplantation,
1. Pfaff, W.W., Howard, R.J. and Scornik, J.C.: Protocol of pretransplant transfusion with
random blood donors: Sensitization and graft results. Transpl. Proc. 14, 1982, pp. 383.
2. Pfaff, W.W., Howard, R.J., Ireland, J. and Scornik, J.: The effect of Lewis antigen and
race on kidney graft survival. Transpl. Proc. 15, 1983, pp. 1139.
3. Scornik, J.C., Ireland, J., Howard, R.J. and Pfaff, W.W.: Mechanisms of induction of
leukocyte antibodies by blood transfusions in previously transplanted patients. Transpl.
Proc. 15, 1983, pp. 1870.
4. Cook, D.J. and Scornik, J.C.: HLA vs non-HLA specificities in sera with broad
anti-lymphocyte reactivity. Transpl. Proc. 17, 1985, pp. 767.
5. Scornik, J.C.: Crossreactive antigens and HLA matching. Transpl. Proc. 19, 1987, pp.
6. Sanfilippo, F., Goeken, N., Niblack, G., Scornik, J.C. and Vaughn, W.K.: The impact
of HLA-A,B match of primary renal allografts subsequent to transplant failure. Transpl.
Proc. 19, 1987, pp. 669.
7 Scornik JC, Salomon DR, Howard RJ, Pfaff WW. Prevention of transfuison induced
broad sensitization in renal transplant candidates. Human Immunol 1988, 23:144.
8. Scornik, J.C., Elfenbein, G., Graham-Pole, J., Goedert, T., Gross, S. and Weiner, R.S.:
Role of anti-donor antibodies in bone marrow transplant rejection: Evaluation by flow
cytometry and effect of plasma exchanges. Transpl. Proc., 21, 1989, pp. 2974-2975.
9. Howard, R.J., Pfaff, W.W., Salomon, D., Peterson, J., Scornik, J.C., et al.: Kidney
transplantation in older patients. Transpl. Proc., 21, 1989, pp. 2020-2021.
10. Scornik JC, Everett ET, Kao KJ, Salomon DR, Davis G. Effect of viral infections and
interferon on erythrocyte, plasma and plaatelet HLA. Human Immunol 1989, 26(ASHI
11. Akkoc, N. Scornik, J.C. Amino Acid residues on HLA molecules critical for
alloantibody binding. Transpl. Proc., 23, 1991, pp. 389.
12. Kao KJ, Small SJ, Scornik JC. Enzyme-linked immunoassay for detection and
quantitation of anti-HLA antibody. Human Immunol 1991, 32(Suppl 1):76.
13. Scornik JC. Detection of anti-Ig but not anti-idiotypic antibodies in transplant patients.
Human Immunol. 1991, 32(Suppl 1):99.
14. Schaub B, Scornik JC, Brunson ME, Longmate JA, Howard RJ, Pfaff WW. Flow
cytometry as the primary crossmatch test. Human Immunol 1992, 34(Suppl 1):46.
15. Scornik JC, Brunson ME, Howard RJ, Pfaff WW, Kao KJ. The monthly panel antibody
debate: Role of a new enzyme immunoassay. Human Immunol 1993, 37(Suppl 1):102.
16. Scornik JC, Metz SJ. Quantitative flow cytometry: The definitive crossmatch. Human
Immunol 1994, 40(Suppl 1):18.
17. Scornik JC, Howard RJ, Pfaff WW, Metz SJ. Blood transfusions as an in vivo test for
alloimmune responsiveness. Human Immunol 1994, 40(Suppl 1): 131.
18. Zaer F, Metz SJ, Scornik JC. Implementation of the pooled soluble HLA ELISA for
antibody screening in a renal transplant program. Human Immunol 1996, 49(Suppl 1):41.
19. Scornik JC, Bray RA, Pollack MS, Cook DJ, Marrari M, Duquesnoy R, Langley JW.
The flow cytometry crossmatch: Evaluation of unknown sera in multiple laboratories.
Human Immunol 1996, 49(Suppl 1):42.
20. Fujita S, Reed A, Rosen C, Howard RJ, Langham MR, Lauwers GY, Scornik JC. High
titer IgG preformed anti-donor antibodies do not affect liver transplant outcome. Human
Immunol 1996, 49(Suppl 1):85.
1975 Antibody-dependent cytotoxicity. University of Mexico, Monterrey, Mexico
1979 In vivo ADCC. National Institutes of Health, Bethesda, MD.
1987 Alloantibody dynamics. American Society of Transplant Physicians-American Society of
Transplant Surgeons joint meeting. Chicago, IL.
1988 Flow cytometry crossmatch. American Society of Histocompatibility and
Immunogenetics (ASHI) Annual meeting workshop, Chicago, IL.
1989 Alloantibody specificity. Clinical Histocompatibility workshop, Palm Springs, CA.
1990 HLA epitope specificity. Clinical Histocompatibility workshop. Kahuku, Hawaii
1990 HLA Sensitization. International Congress of the Transplantation Society (session chair).
San Francisco, CA.
1991 Epitope matching. Clinical Histocompatibility workshop, Palm Springs, CA.
1992 Flow cytometry crossmatch. Clinical Cytometry Society, Charleston, SC.
1992 Alloimmunization to HLA Class I antigens. American Association of Blood Banks. San
1992 Immunogenetic factors in Bone Marrow Transplantation. Egyptian Society of
Hematology, Tanta, Egypt.
1993 Faculty, Laboratory Inspector Seminar. College of American Pathologists, Orlando, FL.
1993 Alloantibody induced hepatitis. Clinical Histocompatibility workshop, Palm
1993 Transplantation Immunogenetics. Honduran Association of Microbiology, Tegucigalpa,
1993 Alloimmunization to HLA Class I antigens. American Association of Blood Banks.
1993 Blood transfusions and alloimmunization. University of South Florida, Tampa, FL.
1993 Alloantibodies in transplantation. Argentine Transplant Congress, Buenos Aires.
1994 Transfusions and alloantibodies. Clinical Histocompatibility workshop, Acapulco,
1995 Crossmatch in transplantation. ASHI workshop, San Antonio, TX
1996 HLA in transplantation. ASHI annual meeting (chair, panel discussion). San Diego, CA